Work

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Year: 2012

Type: review

Source: Inflammopharmacology

DOI: 10.1007/s10787-011-0111-7

Authors: Michael Maes, Zdenĕk Fišar, Miguel Medina, Giovanni Scapagnini, Gabriel Nowak, Michael Berk

Institutions: Charles University, General University Hospital in Prague, University of Molise, Jagiellonian University, Mental Health Research Institute, The University of Melbourne

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2008971294

FWCI: 4.5

Cites: 298

Cited by: 330

Related to: 10